Daigen Xu
7Patents
3h-index
24Co-inventors
57Inventor score
Filing activity: Apr 25, 1997 → Oct 28, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9346872B2 | Interleukin-10 fusion proteins | Chemistry; Metallurgy | 42 | Active |
| US6159948A | Therapeutic and drug screening methods for the treatment and prevention of neuronal disease | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6709866B2 | Methods for enhancing survival of a neuron | Emerging Cross-Sectional Technologies | 10 | Expired |
| US10040843B2 | Interleukin-10 fusion proteins and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US11485786B2 | Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders | Chemistry; Metallurgy | 1 | Active |
| US10012650B2 | Assays for BTK inhibitors | Physics | 0 | Active |
| US12054549B2 | Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.